89 related articles for article (PubMed ID: 3773632)
1. Natural killer cell activity in patients with carcinoma of the larynx and hypopharynx.
Ghoneum M; Gill G; Perry L
Laryngoscope; 1986 Nov; 96(11):1300. PubMed ID: 3773632
[No Abstract] [Full Text] [Related]
2. Natural killer cell activity in patients with carcinoma of the larynx and hypopharynx.
Wustrow TP; Zenner HP
Laryngoscope; 1985 Nov; 95(11):1391-400. PubMed ID: 3903404
[TBL] [Abstract][Full Text] [Related]
3. [The value of CEA in post-therapeutic monitoring of head and neck carcinoma].
Fiorella R; Di Nicola V; Giannubilo C; Facondo M
Acta Otorhinolaryngol Ital; 1988; 8(2):133-6. PubMed ID: 3188902
[No Abstract] [Full Text] [Related]
4. [Role of computerized tomography in the TNM staging of laryngeal and hypopharyngeal neoplasms].
Querin F; Barzan L; Galassi G; Piazza P; Coran F; Galofaro G; Lutman M
Radiol Med; 1986 Dec; 72(12):947-50. PubMed ID: 3797718
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity.
Lutz CT; Kurago ZB
Cancer Res; 1999 Nov; 59(22):5793-9. PubMed ID: 10582701
[TBL] [Abstract][Full Text] [Related]
6. [Cellular immunity in 3 siblings with cancers of the upper aerodigestive tract].
Kürten C
Laryngorhinootologie; 1990 Jan; 69(1):21-3. PubMed ID: 2310457
[TBL] [Abstract][Full Text] [Related]
7. Evidence of existence of low dose radiation induced tumor immunity.
Ogawa Y; Maeda T; Seguchi H; Hamada F; Inomata T; Nishioka M; Kamiike O; Morita M; Ohara S; Yoshida S
Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jun; 47(6):845-8. PubMed ID: 3684526
[No Abstract] [Full Text] [Related]
8. [Study of various immunologic indicators in patients with laryngopharyngeal cancer before and after administration of T-activin].
Nummaev GM; Drevnina NA
Vestn Otorinolaringol; 1989; (1):67. PubMed ID: 2785312
[No Abstract] [Full Text] [Related]
9. E-rosette forming cells (E-RFC) in squamous cell carcinoma of the larynx and laryngopharynx.
Wig U; Saini AS; Gupta VK
J Laryngol Otol; 1983 Jun; 97(6):527-30. PubMed ID: 6602858
[TBL] [Abstract][Full Text] [Related]
10. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
11. Abnormal dinitrochlorobenzene skin sensitization: a prognostic sign of survival in head and neck squamous cell carcinoma.
Maisel RH; Ogura JH
Laryngoscope; 1973 Dec; 83(12):2012-9. PubMed ID: 4772104
[No Abstract] [Full Text] [Related]
12. [Cancer of the larynx and the hypopharynx. Epidemiology, diagnosis, treatment].
Lallemant JG
Rev Prat; 1990 Feb; 40(4):369-74. PubMed ID: 2305202
[No Abstract] [Full Text] [Related]
13. Tissue detection of natural killer cells in laryngeal carcinoma.
Lazaris AC; Segas JV; Nikolopoulos TP; Patsouris ES
Neoplasma; 2007; 54(5):379-82. PubMed ID: 17688367
[TBL] [Abstract][Full Text] [Related]
14. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx.
Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Yoshida T; Nishimura G; Ishitoya J; Katori H
Acta Otolaryngol; 2006 Apr; 126(4):408-13. PubMed ID: 16608794
[TBL] [Abstract][Full Text] [Related]
15. [Immunological changes with prognostic significance in malignant pharyngo-laryngeal tumors].
Suceava I; Simu G
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1981; 26(1):53-8. PubMed ID: 6454219
[No Abstract] [Full Text] [Related]
16. Pharyngeal carcinoma and natural killer cell activity.
Schantz SP; Campbell BH; Guillamondegui OM
Am J Surg; 1986 Oct; 152(4):467-74. PubMed ID: 3766883
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of serum T-lymphocyte subsets and NK cell activity in patients with hypopharyngeal squamous cell carcinoma].
Chen WK; Song M; Chen FJ; Guo ZM; He LR; Yan SL
Ai Zheng; 2006 Oct; 25(10):1300-2. PubMed ID: 17059781
[TBL] [Abstract][Full Text] [Related]
18. Management of the parathyroids in surgery for advanced malignancy of the larynx and hypopharynx.
Freeman JL; Dindzans LJ; Noyek AM
J Otolaryngol; 1985 Dec; 14(6):387-90. PubMed ID: 4078962
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx.
Liu M; Lawson G; Delos M; Jamart J; Chatelain B; Remacle M; Marbaix E
Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):28-34. PubMed ID: 12520353
[TBL] [Abstract][Full Text] [Related]
20. [Salvage surgery in laryngeal and hypopharyngeal carcinoma].
Pawlik AB; Stöckli SJ; Schmid S
Schweiz Med Wochenschr Suppl; 2000; 116():27S-30S. PubMed ID: 10780066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
